The "Cardiac Rhythm Management Market Analysis, Size, Trends | United States | 2019-2025" report has been added to ResearchAndMarkets.com's offering.
In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR in the mid single digits.
This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators, electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.
Key Topics Covered:
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
1. EXECUTIVE SUMMARY
1.1 U.S. Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
1.2 Competitive Analysis
1.3 Market Trends
1.4 Market Developments
1.5 Procedure Numbers
1.6 Procedure Codes Investigated
1.7 Markets Included
1.8 Key Report Updates
1.9 Version History
1.10 Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
2. DISEASE OVERVIEW
2.1 Introduction
2.2 Types Of Arrhythmias
2.2.11 Atrial Fibrillation
2.2.12 Bradycardia
2.2.13 Conduction Disorders
2.2.13.1 Bundle Branch Block
2.2.13.2 Heart Block
2.2.13.3 Long Qt Syndrome (Lqts)
2.2.14 Premature Contractions: Pacs And Pvcs
2.2.15 Tachycardia
2.2.16 Ventricular Fibrillation
2.2.17 Other Rhythm Disorders
2.2.17.1 Adams-Stokes Disease
2.2.17.2 Atrial Flutter
2.2.17.3 Sick Sinus Syndrome
2.2.17.4 Sinus Arrhythmia
2.2.17.5 Wolff-Parkinson-White Syndrome (Wpw)
2.2.18 Types Of Arrhythmia In Children
2.3 Heart Failure
2.4 Cardiac Arrest
2.5 Patient Demographics
2.5.11 Atrial Fibrillation
2.5.12 Bradycardia
2.5.13 Conduction Disorders
2.5.14 Premature Contractions - Pacs And Pvcs
2.5.15 Tachycardia
2.5.16 Ventricular Fibrillation
2.5.17 Other Rhythm Disorders
3. PRODUCT ASSESSMENT
3.1 Introduction
3.2 Product Portfolios
3.2.1 Pacemakers
3.2.2 Implantable Cardioverter Defibrillators (Icds)
3.2.3 Cardiac Resynchronization Therapy (Crt) Devices
3.2.4 Cardiac Leads
3.2.5 External Defibrillators
3.2.6 Lab Systems
3.2.7 Diagnostic Ep Catheters
3.2.8 Cardiac Ablation Catheters
3.3 Fda Recalls
3.4 Clinical Trials
4. U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW
4.1 Introduction
4.2 Market Overview
4.3 Trend Analysis By Segment
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
4.6 Mergers And Acquisitions
4.7 Company Profiles
4.7.1 Abbott
4.7.2 Biosense Webster
4.7.3 Biotronik
4.7.4 Boston Scientific
4.7.5 Cardiac Science
4.7.6 Ge Healthcare
4.7.7 Medtronic
4.7.8 Microport
4.7.9 Zoll
4.8 Swot Analysis
5. PROCEDURE NUMBERS
5.1 Introduction
5.2 Procedures
5.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures
6. PACEMAKER MARKET
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis And Forecast
6.4 Price Analysis
6.5 Drivers And Limiters
6.6 Competitive Market Share Analysis
7. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis And Forecast
7.4 Drivers And Limiters
7.5 Competitive Market Share Analysis
8. CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis And Forecast
8.4 Drivers And Limiters
8.5 Competitive Market Share Analysis
9. CARDIAC LEADS MARKET
9.1 Introduction
9.1.1 Replacement Of Leads
9.2 Market Overview
9.3 Market Analysis And Forecast
9.4 Drivers And Limiters
9.5 Competitive Market Share Analysis
10. ELECTROCARDIOGRAPHY MONITORING MARKET
10.1 Introduction
10.2 Market Overview
10.3 Market Analysis And Forecast
10.4 Drivers And Limiters
10.5 Competitive Market Share Analysis
11. LAB SYSTEMS MARKET
11.1 Introduction
11.2 Market Overview
11.3 Market Analysis And Forecast
11.4 Drivers And Limiters
11.5 Competitive Market Share Analysis
12. DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS MARKET
12.1 Introduction
12.2 Market Overview
12.3 Market Analysis And Forecast
12.4 Drivers And Limiters
12.5 Competitive Market Share Analysis
13. CARDIAC ABLATION CATHETER MARKET
13.1 Introduction
13.2 Market Overview
13.3 Market Analysis And Forecast
13.4 Drivers And Limiters
13.5 Competitive Market Share Analysis
17. ABBREVIATIONS
For more information about this report visit https://www.researchandmarkets.com/r/k3mawr
View source version on businesswire.com: https://www.businesswire.com/news/home/20200121005646/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900